drugset / Trial / NCT00440427
Study Evalutating the Pharmacokinetics (PK) and Safety of a Single Dose of Desvenlafaxine Sustained Release (DVS SR)
RandomizedParallel-groupOpen-labelTreatment
Summary
To assess the initial pharmacokinetic profile of single doses of 25mg and 50 mg of DVS SR to healthy subjects.
Timeline
- Start
- 2007-02
- Primary completion
- —
- Completion
- 2007-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Desvenlafaxine | Other / unclassified | 25 mg | — |
| Subject | Desvenlafaxine | Other / unclassified | 50 mg | — |